Oncodia closes Seed Round of MSEK 4

Oncodia raised MSEK 4 on May 15, 2019 from private and public investors to support development and market launch of its regulatory compliant software for mutation diagnostics in cancer. The round was led by Nolsterby Invest AB, an investor focused on medical device commercialization, The Mats Paulsson Foundation for Research, Innovation and Community Building, Uppsala University Holding AB, and private investors.